Related references
Note: Only part of the references are listed.Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
Maxine M. Denniston et al.
ANNALS OF INTERNAL MEDICINE (2014)
Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010
Reena Mahajan et al.
CLINICAL INFECTIOUS DISEASES (2014)
Hospitalizations And Costs Associated With Hepatitis C And Advanced Liver Disease Continue To Increase
Fujie Xu et al.
HEALTH AFFAIRS (2014)
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
Sylvie Deuffic-Burban et al.
JOURNAL OF HEPATOLOGY (2014)
Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial
Eric Lawitz et al.
LANCET (2014)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Cost Effectiveness of Direct-Acting Antiviral Therapy for Treatment-Naive Patients With Chronic HCV Genotype 1 Infection in the Veterans Health Administration
Kee Chan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study
Anne C. Moorman et al.
CLINICAL INFECTIOUS DISEASES (2013)
Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort
Scott D. Holmberg et al.
CLINICAL INFECTIOUS DISEASES (2013)
Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States
Mark H. Eckman et al.
CLINICAL INFECTIOUS DISEASES (2013)
The Impact of Timing and Prioritization on the Cost-Effectiveness of Birth Cohort Testing and Treatment for Hepatitis C Virus in the United States
Phil McEwan et al.
HEPATOLOGY (2013)
Chronic hepatitis C virus (HCV) disease burden and cost in the United States
Homie Razavi et al.
HEPATOLOGY (2013)
Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals
Natasha K. Martin et al.
HEPATOLOGY (2013)
All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses
L. M. Hagan et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Hepatitis C in the United States
Scott D. Holmberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal
Elamin H. Elbasha et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2013)
The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in US Primary Care Settings
David B. Rein et al.
ANNALS OF INTERNAL MEDICINE (2012)
New Protease Inhibitors for the Treatment of Chronic Hepatitis C A Cost-Effectiveness Analysis
Shan Liu et al.
ANNALS OF INTERNAL MEDICINE (2012)
The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
Kathleen N. Ly et al.
ANNALS OF INTERNAL MEDICINE (2012)
Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C
Phillip O. Coffin et al.
CLINICAL INFECTIOUS DISEASES (2012)
Hepatitis B and C Virus Infection Among 1.2 Million Persons With Access to Care: Factors Associated With Testing and Infection Prevalence
Philip R. Spradling et al.
CLINICAL INFECTIOUS DISEASES (2012)
Economic model of a birth cohort screening program for hepatitis C virus
Lisa J. McGarry et al.
HEPATOLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C
Rebecca Townsend et al.
VALUE IN HEALTH (2011)
Hepatitis C treatment completion rates in routine clinical care
Adeel A. Butt et al.
LIVER INTERNATIONAL (2010)
Public Health Impact of Antiviral Therapy for Hepatitis C in the United States
Michael L. Volk et al.
HEPATOLOGY (2009)
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
Hla-Hla Thein et al.
HEPATOLOGY (2008)
Psychological impact of chronic hepatitis C: Comparison with other stressful life events and chronic diseases
Laurent Castera et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment
BMR Spiegel et al.
HEPATOLOGY (2005)
Improving the accuracy of long-term prognostic estimates in hepatitis C virus infection
Q Yi et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Chronic hepatitis C virus infection: Does it really impact health-related quality of life? A study in rural Egypt
M Schwarzinger et al.
HEPATOLOGY (2004)
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
D Bernstein et al.
HEPATOLOGY (2002)
Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C - A cost-effectiveness analysis
JB Wong et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
